Endocrinology · Thyroid Neoplasms
The facts most likely to be tested
Papillary thyroid carcinoma is the most common type of thyroid malignancy and is strongly associated with a history of childhood head and neck radiation.
Histopathology classically reveals Orphan Annie eye nuclei (clear, ground-glass nuclei) and psammoma bodies (laminated calcifications).
The presence of nuclear grooves and intranuclear cytoplasmic inclusions are highly characteristic diagnostic features on fine-needle aspiration.
Papillary thyroid cancer typically spreads via the lymphatic system to regional cervical lymph nodes rather than hematogenously.
The BRAF V600E mutation is the most frequently identified genetic alteration associated with the pathogenesis of papillary thyroid carcinoma.
Initial management for localized disease involves thyroidectomy followed by levothyroxine therapy to suppress thyroid-stimulating hormone (TSH) levels.
Post-operative surveillance for recurrence is monitored using serial thyroglobulin levels and neck ultrasound.
Vignette unlocked
A 34-year-old female presents for evaluation of a painless, firm thyroid nodule discovered during a routine physical exam. She has no history of neck pain, dysphagia, or hoarseness, and her TSH level is within normal limits. She reports a history of radiation therapy for acne as a child. Fine-needle aspiration of the nodule reveals cells with ground-glass nuclei and nuclear grooves.
What is the most likely diagnosis?
Papillary thyroid carcinoma
The patient's history of childhood radiation and the pathognomonic findings of 'Orphan Annie eye' (ground-glass) nuclei and nuclear grooves on FNA are diagnostic for papillary thyroid carcinoma.
Full handout
High yield triage
Etiology / Epidemiology
Most common thyroid malignancy (80%); associated with prior head/neck radiation exposure.
Clinical Manifestations
Painless, firm thyroid nodule; Orphan Annie eye nuclei on histology.
Diagnosis
Fine needle aspiration (FNA) is the gold standard for initial evaluation.
Treatment
Thyroidectomy is the primary treatment; levothyroxine for TSH suppression.
Prognosis
Excellent prognosis with >95% 10-year survival rate.
Full handout
Epidemiology & Etiology
Papillary thyroid carcinoma is the most common endocrine malignancy, typically affecting women aged 30–50. A major risk factor is childhood head and neck radiation. It is often sporadic but can be associated with Gardner syndrome or Cowden syndrome.
Pertinent Anatomy
The tumor arises from follicular cells. It frequently spreads via the lymphatic system to regional cervical lymph nodes, unlike follicular carcinoma which spreads hematogenously.
Pathophysiology
Driven by BRAF mutations or RET/PTC rearrangements. The tumor is characterized by slow growth and the formation of papillary structures with central fibrovascular cores.
Clinical Manifestations
Patients typically present with a painless, firm, fixed thyroid nodule. Hoarseness or dysphagia suggests local invasion of the recurrent laryngeal nerve or esophagus. Physical exam may reveal palpable cervical lymphadenopathy, a sign of lateral aberrant thyroid metastasis.
Diagnosis
The Fine needle aspiration (FNA) is the diagnostic test of choice for any nodule >1 cm. Histology reveals Orphan Annie eye nuclei (cleared chromatin) and Psammoma bodies (laminated calcifications). Thyroid ultrasound is used to assess nodule characteristics and cervical lymph nodes.
Treatment
Surgical Total thyroidectomy is the standard of care for most patients. Post-operative Radioactive iodine (I-131) ablation is indicated for high-risk patients to destroy residual tissue. Levothyroxine is used for TSH suppression therapy to prevent recurrence, but avoid in patients with cardiac arrhythmias.
Prognosis
The prognosis is excellent with a >95% 10-year survival rate. Long-term monitoring requires serial Thyroglobulin levels to detect recurrence, as it serves as a sensitive tumor marker.
Differential Diagnosis
Follicular carcinoma: hematogenous spread, not lymphatic
Medullary carcinoma: elevated calcitonin, MEN 2 association
Anaplastic carcinoma: rapid growth, elderly, highly aggressive
Thyroid adenoma: benign, encapsulated, no malignant features
Hashimoto thyroiditis: diffuse enlargement, anti-TPO antibodies